Adaptin Bio (APTN) Shares Outstanding (2022 - 2026)

Adaptin Bio has disclosed Shares Outstanding (Entity) across 5 years of filings, most recently posting $9.1 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 7.07% year-over-year to $9.1 million; the TTM figure through Jun 2026 stood at $9.1 million (up 7.07% YoY), while the FY2025 annual figure was $8.7 million, up 73.12% from the prior year.
• Shares Outstanding (Entity) came in at $9.1 million for Q2 2026 at Adaptin Bio, up from $8.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $9.1 million in Q2 2026 to a low of $5.0 million in Q4 2022.
• Average Shares Outstanding (Entity) over 5 years is $6.5 million, with a median of $5.0 million recorded in 2022.
• Year-over-year, Shares Outstanding (Entity) changed 0.0% in 2023 and soared 73.12% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $5.0 million in 2022, then changed by 0.0% to $5.0 million in 2023, then changed by 0.0% to $5.0 million in 2024, then surged by 73.12% to $8.7 million in 2025, then rose by 4.59% to $9.1 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $9.1 million in Q2 2026, $8.8 million in Q1 2026, and $8.7 million in Q4 2025.